Co-Diagnostics, Inc. Quarterly Cost of Revenue in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Co-Diagnostics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2017 to Q3 2024.
  • Co-Diagnostics, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $297K, a 16.3% increase year-over-year.
  • Co-Diagnostics, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $3.71M, a 114% increase year-over-year.
  • Co-Diagnostics, Inc. annual Cost of Revenue for 2023 was $4.18M, a 23.6% decline from 2022.
  • Co-Diagnostics, Inc. annual Cost of Revenue for 2022 was $5.48M, a 52.6% decline from 2021.
  • Co-Diagnostics, Inc. annual Cost of Revenue for 2021 was $11.6M, a 30.2% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.71M $297K +$41.6K +16.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $3.67M $212K -$247K -53.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $3.92M $235K -$268K -53.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.18M $2.97M +$2.45M +475% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $1.73M $256K -$512K -66.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.25M $459K -$456K -49.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.7M $502K -$2.78M -84.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $5.48M $516K -$1.97M -79.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $7.45M $768K -$2.54M -76.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $10M $915K -$1.59M -63.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $11.6M $3.28M +$9.39K +0.29% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $11.6M $2.49M -$1.83M -42.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $13.4M $3.31M -$2.51M -43.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $15.9M $2.5M -$3.47M -58.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $19.4M $3.27M +$2.79M +579% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $16.6M $4.31M +$4.71M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 $11.9M $5.82M +$5.8M +28485% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $6.08M $5.98M +$5.94M +15297% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $142K $482K +$29.7K +6.58% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $112K -$399K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 $20.4K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $38.8K Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-11-03
Q1 2019 $452K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q2 2017 $302* Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.